Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin
International Archives of Allergy and Immunology · 2024
DOI: 10.1159/000541100 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Zhisen Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Functional and Clinical Translational Medicine, Xiamen Key Laboratory of Respiratory Diseases, Xiamen Medical Col…. Hauptthemen laut MEDLINE: Asthma, Flavonoids, Cytokines, Th2 Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Introduction
Baicalin is a flavonoid chemical extracted and purified from the traditional Chinese medicine named Scutellaria baicalensis Georgi, which possesses broad pharmacological properties. Our work aimed to explore the protective role of baicalin in allergic asthma and its potential mechanisms on regulating type 2 immune response.
Methods
Mice were injected intraperitoneally with ovalbumin (OVA) twice, further challenged with OVA aerosol for continuous 5 days. For baicalin group, mice were pre-administrated with baicalin. After the final challenge, the immune cells in bronchoalveolar lavage fluid (BALF) and blood were examined. The cytokines were evaluated by ELISA. Histological inspections were examined by hematoxylin and eosin staining and Periodic Acid-Schiff staining. Thymic stromal lymphopoietin (TSLP) expression in lungs were detected using immunohistochemistry and Western blotting.
Results
The eosinophils infiltrating in BALF were reduced remarkably in baicalin-treated asthmatic mice. Baicalin decreased OVA-induced inflammatory cytokines and total serum immunoglobulin E secretion significantly. Moreover, baicalin alleviated the asthmatic pathological changes and substantially suppressed TSLP expression in the lung tissues.
Conclusion
Our study indicates that baicalin attenuates OVA-induced allergic asthma in mice effectively by suppressing type 2 immune responses, which might provide a novel insight into the anti-asthmatic activity of baicalin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Functional and Clinical Translational Medicine, Xiamen Key Laboratory of Respiratory Diseases, Xiamen Medical College, Xiamen, China.
- Department of Pharmacy, Xiamen Medical College, Xiamen, China.
- Department of Clinical Medicine, Xiamen Medical College, Xiamen, China.
- Department of Microbiology and Immunology, Xiamen Medical College, Xiamen, China.
Zitieren
APA
Zeng, Z., Ruan, Y., Ying, H., Wang, J., Wang, H., & Chen, S. (2024). Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin. International Archives of Allergy and Immunology. https://doi.org/10.1159/000541100
Vancouver
Zeng Z, Ruan Y, Ying H, Wang J, Wang H, Chen S. Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin. International Archives of Allergy and Immunology. 2024. doi:10.1159/000541100
BibTeX
@article{Zeng2024,
author = {Zeng, Zhisen and Ruan, Yaoxin and Ying, Haoran and Wang, Jie and Wang, Huangbin and Chen, Shuzhen},
title = {Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin},
journal = {International Archives of Allergy and Immunology},
year = {2024},
doi = {10.1159/000541100}
}
EUVIMED